CRMI

8158
0.2380.83% ( -0.002 )
Delay Closed: Nov 16, 16:08:00

Valuation

Current ValuationThe current P/E ratio is 2.63, within the reasonable range, cheaper than 69.25% of the time in the past 5 years, and the industry ranks 2/78, the industry Median -4.86.

2.63xP/E
Stock priceHK$0.24Earnings per shareHK$0.09

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0152304456608

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09995HKREMEGEN
4.71x512.28%HK$35.84B
01530HK3SBIO
3.72x71.78%HK$35.42B
09969HKINNOCARE
12.55x6.83%HK$19.92B
02142HKHBM HOLDINGS-B
13.43x8.46%HK$8.90B
01167HKJACOBIO-B
5.50x--HK$3.25B
02509HKQYUNS-B
5.12x23.95%HK$3.22B
06998HKEDDING GENOR
12.24x--HK$3.09B
02197HKCLOVER BIO-B
2.19x--HK$2.15B
01061HKESSEX BIO-TECH
4.26x1.60%HK$1.13B
02566HKJIUYUAN GENE
6.27x--HK$1.01B
00690HKUNI-BIO GROUP
7.75x--HK$376.19M
08158HKCRMI
2.63x--HK$72.41M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.